These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Proton magnetic resonance spectroscopy: clinical applications in patients with brain lesions. Ramin SL; Tognola WA; Spotti AR Sao Paulo Med J; 2003 Nov; 121(6):254-9. PubMed ID: 14989143 [TBL] [Abstract][Full Text] [Related]
7. Restitution of visual functions in cerebrally blind children. Werth R; Seelos K Neuropsychologia; 2005; 43(14):2011-23. PubMed ID: 15876440 [TBL] [Abstract][Full Text] [Related]
8. Cerebral polyopia with extrastriate quadrantanopia: report of a case with magnetic resonance documentation of V2/V3 cortical infarction. Jones MR; Waggoner R; Hoyt WF J Neuroophthalmol; 1999 Mar; 19(1):1-6. PubMed ID: 10098539 [TBL] [Abstract][Full Text] [Related]
10. Combined magnetic resonance imaging and proton magnetic resonance spectroscopy of patients with acute stroke. Felber SR; Aichner FT; Sauter R; Gerstenbrand F Stroke; 1992 Aug; 23(8):1106-10. PubMed ID: 1636186 [TBL] [Abstract][Full Text] [Related]
11. What might be the impact on neurology of the analysis of brain metabolism by in vivo magnetic resonance spectroscopy? Vion-Dury J; Meyerhoff DJ; Cozzone PJ; Weiner MW J Neurol; 1994 May; 241(6):354-71. PubMed ID: 7931430 [TBL] [Abstract][Full Text] [Related]
12. Homonymous quadrantanopia respecting the horizontal meridian. A feature of striate and extrastriate cortical disease. McFadzean RM; Hadley DM Neurology; 1997 Dec; 49(6):1741-6. PubMed ID: 9409385 [TBL] [Abstract][Full Text] [Related]
13. MR-spectroscopic imaging during visual stimulation in subgroups of migraine with aura. Sándor PS; Dydak U; Schoenen J; Kollias SS; Hess K; Boesiger P; Agosti RM Cephalalgia; 2005 Jul; 25(7):507-18. PubMed ID: 15955037 [TBL] [Abstract][Full Text] [Related]
14. Detection of visual dysfunction in optic atrophy by functional magnetic resonance imaging during monocular visual stimulation. Miki A; Nakajima T; Takagi M; Shirakashi M; Abe H Am J Ophthalmol; 1996 Sep; 122(3):404-15. PubMed ID: 8794713 [TBL] [Abstract][Full Text] [Related]
15. Functional magnetic resonance imaging of the primary visual cortex: evaluation of human afferent visual system. Miki A; Nakajima T; Fujita M; Wantanabe H; Kuwabara T; Naruse S; Takagi M; Abe H Jpn J Ophthalmol; 1995; 39(3):302-8. PubMed ID: 8577083 [TBL] [Abstract][Full Text] [Related]
16. Multiparametric Imaging Analysis: Magnetic Resonance Spectroscopy. Rapalino O; Ratai EM Magn Reson Imaging Clin N Am; 2016 Nov; 24(4):671-686. PubMed ID: 27742109 [TBL] [Abstract][Full Text] [Related]
17. Investigations of the human visual system using functional magnetic resonance imaging (FMRI). Kollias SS Eur J Radiol; 2004 Jan; 49(1):64-75. PubMed ID: 14975494 [TBL] [Abstract][Full Text] [Related]
18. Structural brain MRI studies in eye diseases: are they clinically relevant? A review of current findings. Prins D; Hanekamp S; Cornelissen FW Acta Ophthalmol; 2016 Mar; 94(2):113-21. PubMed ID: 26361248 [TBL] [Abstract][Full Text] [Related]
19. Proton MR spectroscopy in neoplastic and non-neoplastic brain disorders. Castillo M; Kwock L; Scatliff J; Mukherji SK Magn Reson Imaging Clin N Am; 1998 Feb; 6(1):1-20. PubMed ID: 9449737 [TBL] [Abstract][Full Text] [Related]
20. [1H magnetic resonance spectroscopy in intracranial tumors and cerebral ischemia]. Felber SR Radiologe; 1993 Nov; 33(11):626-32. PubMed ID: 8278589 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]